Delic s Acquisition Target, Ketamine Infusion Centers, Announces Proposal to Acquire 2 Additional Clinic Locations
News provided by
Share this article
VANCOUVER, BC, May 11, 2021 /PRNewswire/ -
Company ) (CSE: DELC) (OTCQB: DELFC) a psychedelic wellness platform, is pleased to announce that its acquisition target (under binding letter agreement see news release dated February 4, 2021),
Ketamine Infusion Centers ( KIC ), proposes to acquire two (2) additional licensed ketamine clinics in Arizona. The proposed acquisition would double the footprint of the infusion chain and become the largest operator in the state of Arizona. This is a major step toward becoming the largest ketamine clinic operator in the country, bringing superior quality and expanding access for patients, said Matt Stang, Delic CEO and co-founder. KIC is the leading name in high quality care and incredible outcomes for its patients and this move helps grow that reputation significantly. As a vital part of
DELIC or the
Company ) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, announces that the Company is not aware of any material undisclosed information and wishes to make the following statements regarding recent sponsored news and marketing activities concerning its shares of common shares traded on the OTCQB market.
On May 6, 2021, OTC Markets Group ( OTC Markets ) sent the Company a copy of a newsletter article published by Financial News Now.com on March 16, 2021 (the Article ) and email distribution between May 6-7 and requested comment from the Company. The article and email discuss recent mental health research, current events in the psychedelics industry, a description of the Company s business plan, board of directors, state of the current market, and matters relating to investment in the Company. The website is owned by IDR Marketing, Inc. ( IDR ), which was retained by the Company to assist with financial marketing efforts in order to increase in
DELIC or the
Company ) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to provide the following shareholder update on its operations for the first quarter of 2021.
The first quarter of 2021 has been transformative and expansive as DELIC has entered into new sectors of this nascent industry. From early beginnings in media with Reality Sandwich, Meet DELIC, & DELIC Radio, DELIC now has begun to execute its M&A strategy by entering into binding agreements with Ketamine Infusion Center ( KIC ), with their clinics located in California and Arizona, and of Complex Biotech Discovery Ventures ( CBDV ) in Vancouver, and more.
Acquisition Transactions:
DELIC or the
Company ) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to announce the acquisition of Homestead brand and intellectual property. Homestead is a legacy counterculture distributor of psychedelic media and creator of one of the first self-contained mushroom grow kits.
Matt Stang, Founder and CEO of DELIC commented, The acquisition of Homestead is an exciting one for us at DELIC. It shows how we are increasing accessibility to this nascent industry within regulated jurisdictions. Homestead not only sold tens of thousands of mushroom kits globally but also was one of the earliest distributors for High Times and many other counter culture publications. We look forward to growing together and increasing shareholder value with what we accomplish.
DELIC or the
Company ) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to announce the appointment of Kyle Snook, former COO of Actify Neurotherapies, to the Board of Advisors of the Company.
Matt Stang commented On behalf of the team at DELIC, I am very excited to welcome Kyle to the Board of Advisors. His multi-faceted background will be an invaluable asset to the team. I look forward to working together and building DELIC to becoming a leader in the sector.
Kyle Snook was the COO of Actify Neurotherapies, a Venture backed multi-site startup formerly the largest provider of IV Ketamine Therapy nationwide. As COO Kyle was responsible for all business operations including multi-site operations and growth, marketing and financial management. Kyle received his undergraduate degree from West Point and served as an Infantry officer in the United States Army, including a combat tour to Afghanistan. Kyle also received his MBA from Harvard Business S